We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-12.93%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$102B
AUM Growth
-$16.3B
Cap. Flow
+$749M
Cap. Flow %
0.73%
Top 10 Hldgs %
23.72%
Holding
4,322
New
210
Increased
1,790
Reduced
1,850
Closed
304
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SF
1551
Stifel
SF
$12.9B
$3.99M ﹤0.01%
106,824
-1,325
-1% -$55K
BEPC icon
1552
Brookfield Renewable
BEPC
$6.66B
$3.99M ﹤0.01%
111,931
+21,185
+23% +$783K
IDHQ icon
1553
Invesco S&P International Developed Quality ETF
IDHQ
$987M
$3.97M ﹤0.01%
166,354
-219,253
-57% -$5.7M
CET
1554
Central Securities Corp
CET
$1.63B
$3.95M ﹤0.01%
112,085
-217,152
-66% -$8.26M
JPI
1555
DELISTED
Nuveen Preferred Securities & Income Opportunities Fund
JPI
$3.94M ﹤0.01%
205,076
-71,904
-26% -$1.48M
IXJ icon
1556
iShares Global Healthcare ETF
IXJ
$4.23B
$3.93M ﹤0.01%
48,456
-932
-2% -$77.9K
DAVA icon
1557
Endava
DAVA
$167M
$3.93M ﹤0.01%
44,504
+1,035
+2% +$108K
NATI
1558
DELISTED
National Instruments Corp
NATI
$3.92M ﹤0.01%
125,661
+2,745
+2% +$97.3K
ALIT icon
1559
Alight
ALIT
$394M
$3.92M ﹤0.01%
29,034
-56,782
-66% -$9.31M
FHB icon
1560
First Hawaiian
FHB
$3.39B
$3.92M ﹤0.01%
172,592
+14,841
+9% +$372K
FBIN icon
1561
Fortune Brands Innovations
FBIN
$5.78B
$3.92M ﹤0.01%
76,489
+1,580
+2% +$92.6K
ADX icon
1562
Adams Diversified Equity Fund
ADX
$3.3B
$3.91M ﹤0.01%
255,087
-524,132
-67% -$8.7M
IQI icon
1563
Invesco Quality Municipal Securities
IQI
$541M
$3.9M ﹤0.01%
381,980
+12,849
+3% +$134K
SCHO icon
1564
Schwab Short-Term US Treasury ETF
SCHO
$13B
$3.9M ﹤0.01%
158,572
+17,020
+12% +$420K
ATCO
1565
DELISTED
Atlas Corp.
ATCO
$3.9M ﹤0.01%
363,816
-14,500
-4% -$182K
RITM icon
1566
Rithm Capital
RITM
$5.79B
$3.89M ﹤0.01%
417,813
+5,389
+1% +$56.6K
IWY icon
1567
iShares Russell Top 200 Growth ETF
IWY
$16.7B
$3.89M ﹤0.01%
31,085
-7,835
-20% -$1.08M
OXY.WS icon
1568
Occidental Petroleum Corp Warrants
OXY.WS
$33.7B
$3.89M ﹤0.01%
105,271
-13,923
-12% -$553K
PLTR icon
1569
Palantir
PLTR
$430B
$3.88M ﹤0.01%
427,669
-203,445
-32% -$2.01M
CRNC icon
1570
Cerence
CRNC
$389M
$3.88M ﹤0.01%
153,588
+545
+0.4% +$16.3K
PLOW icon
1571
Douglas Dynamics
PLOW
$967M
$3.87M ﹤0.01%
134,627
+7,063
+6% +$220K
VLY icon
1572
Valley National Bancorp
VLY
$8.3B
$3.87M ﹤0.01%
371,634
+26,964
+8% +$320K
KBH icon
1573
KB Home
KBH
$3.45B
$3.87M ﹤0.01%
135,913
-105,394
-44% -$3.37M
UDR icon
1574
UDR
UDR
$12.2B
$3.86M ﹤0.01%
83,904
+3,175
+4% +$160K
FND icon
1575
Floor & Decor
FND
$6.27B
$3.86M ﹤0.01%
61,309
+32,662
+114% +$2.46M

Similar funds

Raymond James & Associates's Q2 2022 Portfolio in Review

As of Q2 2022, Raymond James & Associates held 4,322 positions worth $102B, down 14% from $119B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q2 2022 filing shows 210 new, 1,790 increased, 1,850 reduced and 304 closed positions. Its largest new stake was Aspen Technology Inc: 54,037 shares worth $9.93M. The largest sale was iShares Core MSCI EAFE ETF, an estimated $551M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q2 2022 buy was Aspen Technology Inc: 54,037 shares worth $9.93M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2022, an estimated $471M increase.
  • Raymond James & Associates's biggest Q2 2022 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $551M.
  • Raymond James & Associates fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $21.5M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $102B portfolio in Q2 2022.
  • Raymond James & Associates opened 210 new positions and closed 304 in Q2 2022.
  • Raymond James & Associates's portfolio value fell 14% quarter-over-quarter to $102B.

Based on Raymond James & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.